|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A Highly Purified Factor Vn/:c Concentrate Prepared from Cryoprecipitate by Ion-exchange Chromatography 显示文摘 | Burnouf T Burnouf-Radosevich M Huart J J | 1991 | Vox Sanguinis1991，60，1： | 1 |
| 2 | Fibrin sealant: scientific rationale, production methods, properties, and current clinical use 显示文摘 | Radosevich M Goubran HA Burnouf T | 1997 | Vox Sang1997，72，： | 1 |
| 3 | Blood-derived biomaterials and platelet growth factors in regenerative medicine显示文摘 | Burnouf T Goubran HA Chen TM | | 0，，02： | 1 |
| 4 | Fribin sealant:scientific rationale,production methods,properties,and current clinical use显示文摘 | Radosevich M Goubran HI Burnouf T | 1997 | Vox Sang1997，72，3： | 1 |
| 5 | Nanofiltration of plasma-derived biopharmaceutical products显示文摘 | Burnouf T Radosevich M | 2003 | Haemophilia2003，9，1： | 1 |
| 6 | Chron~mgraphy in plasma fractionation:Benefits and future trends显示文摘 | Burnouf T | | 0，，01： | 1 |
| 7 | Fibrin sealant: scientific rationale, production methods, properties, and current clinical use 显示文摘 | Radosevich M Goubran HI Burnouf T | 1997 | Vox Sang1997，72，3： | 1 |
| 8 | Fibrin sealant: scientific rationale, production methods, properties, and current clinical use 显示文摘 | RADOSEVICH M GOUBRAN H I BURNOUF T | 1997 | Vox Sang1997，72，3： | 1 |
| 9 | The platelet-cancer loop显示文摘 | Goubran H Burnouf T Radosevic M | 2013 | Eur J Int Med2013，24，5： | 1 |
| 10 | In vitro release of grow th factors from platelet -rich fibrin(PRF):a proposal to op-timize the clinical applications of PRF显示文摘 | Su CY Kuo YP Tseng Y H Su CH Burnouf T | | 0，，01： | 1 |
| 11 | Gluten in subunits of genetically related European hexaploid wheat cultivars;their relation to bread-making quality显示文摘 | Burnouf T Bouriquet R | 1980 | Theoritical Applied Genetics1980，58，： | 1 |
| 12 | Properties of a highly purified human plasma Factor IX:c therapeutic concentrate prepared by conventional chromatography显示文摘 | Burnouf T Michalski C Goudemand M | | 0，，： | 1 |
| 13 | Fibrin sealant:scientific rationale,production methods,properties,and current clinical use显示文摘 | Radosevich M Goubran HI Burnouf T | 1997 | Vox Sang1997，72，3： | 1 |
| 14 | Chromatography in plasma fractionation: benefits and future trends 显示文摘 | Burnouf T | 1995 | J Chromatogr B1995，664，1： | 1 |
| 15 | Intravenous immunoglobulin G:trends in production methods,quality control and quality assurance显示文摘 | Radosevich M Burnouf T | 2010 | Vox Sang2010，98，1： | 1 |
| 16 | A highly purified factorⅧ:c concentrate prepared from cryoprecipitate by ion-exchange chromatography显示文摘 | Burnouf T Burnouf-Radosevich M Huart JJ | 1991 | Vox Sang1991，60，1： | 1 |
| 17 | Fibrin sealant:scientific rationale,production methods,properties,and current clinical use显示文摘 | Radosevich M Goubran HA Burnouf T | | 0，，03： | 1 |
| 18 | Application of bioaffinity technology in therapeutic extracorporeal plasmapheresis and largescale fractionation of human plasma显示文摘 | Burnouf T Goubran H A Radosevieh M | | 0，，： | 1 |
| 19 | Fibrin sealant:scientific rationale,production methods,properties,and current clinical use显示文摘 | Radosevich M Goubran HI Burnouf T | 1997 | Vox Sang1997，72，3： | 1 |
| 20 | A minipllo process for solvent-detergent treatment of eryoprecipitate at blood centres using a disposable bag system显示文摘 | Burnouf T Goubra H Radosevich M | 2006 | Vox Sang2006，91，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员